Hyep Ivan Insider Trading Activity
Hyep Ivan has been net-selling over the last 12 months with 0 purchases and 13 sales across 1 company.
BCAX is the most-traded position with 13 trades. The largest single transaction was a sale of BCAX for $332K on Oct 7, 2025.
Performance Scorecard
Forward stock performance after each transaction by Hyep Ivan. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +4.8% | 67% | 12 |
| 90 days | — | +1.3% | 60% | 10 |
| 120 days | — | +0.6% | 63% | 8 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersBCAX · Bicara Therapeutics Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Hyep Ivan bought and sold BCAX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| May 21, 2026 | BCAX | Sell | 9,200 | $20.42 | $188K | CFO |
| Apr 21, 2026 | BCAX | Sell | 9,200 | $23.00 | $212K | CFO |
| Mar 23, 2026 | BCAX | Sell | 9,200 | $18.52 | $170K | CFO |
| Mar 4, 2026 | BCAX | Sell | 2,963 | $18.25 | $54K | CFO |
| Mar 3, 2026 | BCAX | Sell | 13,555 | $18.22 | $247K | CFO |
| Jan 22, 2026 | BCAX | Sell | 1,882 | $18.15 | $34K | CFO |
| Dec 22, 2025 | BCAX | Sell | 9,200 | $18.31 | $168K | CFO |
| Nov 24, 2025 | BCAX | Sell | 17,795 | $18.55 | $330K | CFO |
| Nov 21, 2025 | BCAX | Sell | 605 | $18.15 | $11K | CFO |
| Oct 9, 2025 | BCAX | Sell | 6,415 | $18.23 | $117K | CFO |
| Oct 8, 2025 | BCAX | Sell | 5,627 | $18.21 | $102K | CFO |
| Oct 7, 2025 | BCAX | Sell | 18,244 | $18.22 | $332K | CFO |
| Oct 6, 2025 | BCAX | Sell | 6,514 | $18.17 | $118K | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 13 | $2.1M |
Other insiders at Bicara Therapeutics Inc.
4 other tracked filers at BCAX.